Future Directions in Mucormycosis Research

被引：38

作者：

Kontoyiannis, Dimitrios P. ^{[1
]}

Lewis, Russell E. ^{[1
]}

Lotholary, Oliver ^{[2
]}

Spellberg, Brad ^{[3
,4
]}

Petrikkos, Georgios ^{[5
]}

Roillides, Emmanuel ^{[6
]}

Ibrahim, Ashraf ^{[3
,4
]}

Walsh, Thomas J. ^{[7
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA

[2] Univ Paris, Hop Necker Enfants Malad, Serv Malad Infect & Trop, Paris, France

[3] Univ Calif Los Angeles, David Geffen Sch Med, Med Ctr,Div Gen Internal Med, Los Angeles Biomed Res Inst Harbor, Los Angeles, CA 90095 USA

[4] Harbor UCLA Med Ctr, Div Infect Dis, Torrance, CA USA

[5] Kapodistriakon Univ Athens, Thessaloniki, Greece

[6] Aristotle Univ Thessaloniki, Hippokrat Hosp, Dept Pediat 3, GR-54006 Thessaloniki, Greece

[7] Cornell Univ, Weill Med Coll, Div Infect Dis, New York Presbyterian Hosp, New York, NY 10021 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2012年 / 54卷

基金：

美国国家卫生研究院;

关键词：

CELL TRANSPLANT RECIPIENTS; INVASIVE FUNGAL-INFECTIONS; PULMONARY ZYGOMYCOSIS; ANTIFUNGAL THERAPY; RHIZOPUS-ORYZAE; AMPHOTERICIN-B; IN-VITRO; IDENTIFICATION; POSACONAZOLE; ASPERGILLUS;

D O I：

10.1093/cid/cir886

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Mucormycosis has emerged as an important opportunistic infection, especially in severely immunosuppressed hosts. The evolving epidemiology, immunopathogenesis, molecular virulence studies, early diagnosis, and pitfalls in designing clinical studies of mucormycosis are discussed in this article.

引用

页码：S79 / S85

页数：7

共 61 条

[1] Spectrum of Zygomycete Species Identified in Clinically Significant Specimens in the United States [J].

Alvarez, E. ;

Sutton, D. A. ;

Cano, J. ;

Fothergill, A. W. ;

Stchigel, A. ;

Rinaldi, M. G. ;

Guarro, J. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (06) :1650-1656

[2] Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors [J].

Ambrosioni, Juan ;

Bouchuiguir-Wafa, Kalthum ;

Garbino, Jorge .

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 :E100-E103

[3] Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications [J].

Andes, David ;

Pascual, Andres ;

Marchetti, Oscar .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (01) :24-34

[4]

[Anonymous], 2005, PRINC PRACT INFECT D

[5] FUNGISTATIC MECHANISM OF HUMAN TRANSFERRIN FOR RHIZOPUS-ORYZAE AND TRICHOPHYTON-MENTAGROPHYTES - ALTERNATIVE TO SIMPLE IRON DEPRIVATION [J].

ARTIS, WM ;

PATRUSKY, E ;

RASTINEJAD, F ;

DUNCAN, RL .

INFECTION AND IMMUNITY, 1983, 41 (03) :1269-1278

[6] A MECHANISM OF SUSCEPTIBILITY TO MUCORMYCOSIS IN DIABETIC-KETOACIDOSIS - TRANSFERRIN AND IRON AVAILABILITY [J].

ARTIS, WM ;

FOUNTAIN, JA ;

DELCHER, HK ;

JONES, HE .

DIABETES, 1982, 31 (12) :1109-1114

[7] Immunopharmacology of modern antifungals [J].

Ben-Ami, R. ;

Lewis, R. E. ;

Kontoyiannis, D. P. .

CLINICAL INFECTIOUS DISEASES, 2008, 47 (02) :226-235

[8] Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites [J].

Ben-Ami, Ronen ;

Lewis, Russell E. ;

Leventakos, Konstantinos ;

Kontoyiannis, Dimitrios P. .

BLOOD, 2009, 114 (26) :5393-5399

[9] A clinicopathological study of pulmonary mucormycosis in cancer patients: Extensive angioinvasion but limited inflammatory response [J].

Ben-Ami, Ronen ;

Luna, Mario ;

Lewis, Russell E. ;

Walsh, Thomas J. ;

Kontoyiannis, Dimitrios P. .

JOURNAL OF INFECTION, 2009, 59 (02) :134-138

[10] ADAPTIVE ASSIGNMENT VERSUS BALANCED RANDOMIZATION IN CLINICAL-TRIALS - A DECISION-ANALYSIS [J].

BERRY, DA ;

EICK, SG .

STATISTICS IN MEDICINE, 1995, 14 (03) :231-246

← 1 2 3 4 5 6 7 →